BioNexus Gene Lab Corp Common stock · Healthcare · Healthcare
As of 2026-06-26, BioNexus Gene Lab Corp Common stock (BGLC) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 16.4%, relative volume 0.00×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
20 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BGLC is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.9% / -39.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BGLC Jan avg: -0.01% median: -11.45% win: 33% σ: 41.19% n: 3 2023-07-21 → 2026-05-29 | BGLC Feb avg: 2.18% median: 4.90% win: 67% σ: 20.58% n: 3 2023-07-21 → 2026-05-29 | BGLC Mar avg: -8.39% median: -21.42% win: 33% σ: 28.28% n: 3 2023-07-21 → 2026-05-29 | BGLC Apr avg: 2.15% median: -1.90% win: 33% σ: 16.75% n: 3 2023-07-21 → 2026-05-29 | BGLC May avg: 9.84% median: 10.48% win: 67% σ: 41.00% n: 3 2023-07-21 → 2026-05-29 | BGLC Jun avg: -8.29% median: -8.29% win: 50% σ: 28.50% n: 2 2023-07-21 → 2026-05-29 (current) | BGLC Jul avg: 24.72% median: 2.63% win: 67% σ: 91.98% n: 3 2023-07-21 → 2026-05-29 | BGLC Aug avg: -16.99% median: -18.04% win: 0% σ: 6.91% n: 3 2023-07-21 → 2026-05-29 | BGLC Sep avg: -17.29% median: -3.70% win: 33% σ: 27.67% n: 3 2023-07-21 → 2026-05-29 | BGLC Oct avg: -23.95% median: -19.10% win: 0% σ: 25.81% n: 3 2023-07-21 → 2026-05-29 | BGLC Nov avg: 24.92% median: -16.24% win: 33% σ: 88.71% n: 3 2023-07-21 → 2026-05-29 | BGLC Dec avg: -12.09% median: -13.00% win: 33% σ: 32.58% n: 3 2023-07-21 → 2026-05-29 |